热门资讯> 正文
iTeos Therapeutics GAAP每股收益为-0.18美元
2024-08-08 20:26
- iTeos Therapeutics press release (NASDAQ:ITOS): Q2 GAAP EPS of -$0.18.
- The Company’s cash, cash equivalents, and investments position was $679.4 million as of June 30, 2024, as compared to $677.5 million as of June 30, 2023.
More on iTeos Therapeutics
- iTeos Therapeutics: Rippling Waves Of TIGIT Pessimism
- Seeking Alpha’s Quant Rating on iTeos Therapeutics
- Historical earnings data for iTeos Therapeutics
- Financial information for iTeos Therapeutics
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
